- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 58.87M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 58.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 64.65M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $4M |
| Capex | Q1 2026 · Mar 31, 2026 | $10.9M |
| Capex | Q1 2026 · Mar 31, 2025 | $7.7M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $88.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $180M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $296.6M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $313.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.65B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.68B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.78B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.8B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.41B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $12.47B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $12.47B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.54 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.56 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | $99.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.11B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.19B |